Fig. 1From: Homoharringtonine is synergistically lethal with BCL-2 inhibitor APG-2575 in acute myeloid leukemiaAPG-2575 showed comparable anti-leukemic effect to ABT-199. A The cell viability of different concentrations of APG-2575 or ABT-199 in HL-60, Kasumi-1, MV4-11 and OCI-AML3 cells for 24 h. B, C The inhibition ratio of APG-2575 and ABT-199 in primary AML at different concentrations for 48 hBack to article page